Overview:

GlobalData’s new report, “Brazil In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Brazil In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Market size and company share data for In Vitro Diagnostics (IVD) market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016.
- 2009 company shares and distribution shares data for each of the seven market categories.
- Global corporate-level profiles of key companies operating within the Brazil In Vitro Diagnostics (IVD) market.
- Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and Becton, Dickinson.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Brazil In Vitro Diagnostics (IVD) competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Companies Mentioned

F. Hoffmann-La Roche Ltd.
Abbott Laboratories
Siemens Healthcare
bioMerieux S.A.
Beckman Coulter, Inc.
Ortho-Clinical Diagnostics Inc.
Inverness Medical Innovations, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Hologic, Inc.
OLYMPUS CORPORATION
Mindray Medical International Limited
Sysmex Corporation
Ventana Medical Systems, Inc.
DiaSorin S.p.A
Qiagen N.V.
Gen-Probe Incorporated
Phadia AB

1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 11
2 Introduction 14
2.1 What is This Report About? 14
3 In Vitro Diagnostics In Brazil 15
3.1 In Vitro Diagnostics, Market Segmentation 15
3.2 In Vitro Diagnostics, Brazil, Overall Revenue ($m), 2002-2016 16
3.3 In Vitro Diagnostics Market, Brazil, Revenue Mix ($m), 2009 18
3.4 In Vitro Diagnostics Market, Brazil, Category Contribution (%), 2009 19
3.5 In Vitro Diagnostics, Brazil, Company Share (2008-2009) 25
4 Clinical Chemistry In Brazil 26
4.1 Clinical Chemistry, Market Segmentation 26
4.2 Clinical Chemistry Market, Brazil, Revenue Mix ($m), 2009 27
4.3 Clinical Chemistry Market, Brazil, Category Contribution (%), 2009 28
4.4 Clinical Chemistry Overall Revenue (2002-2016) 29
4.4.1 Clinical Chemisty Analyzers Revenue (2002-2016) 33
4.4.2 Urine Analysis Revenue (2002-2016) 37
4.5 Clinical Chemistry Distribution Share (2008-2009) 41
4.6 Clinical Chemistry, Brazil, Company Share (2008-2009) 42
5 Genetic Testing In Brazil 44
5.1 Genetic Testing, Market Segmentation 44
5.2 Genetic Testing Market, Brazil, Revenue Mix ($m), 2009 45
5.3 Genetic Testing Market, Brazil, Category Contribution (%), 2009 46
5.4 Genetic Testing Overall Revenue (2002-2016) 47
5.5 Genetic Testing Distribution Share (2008-2009) 51
5.6 Genetic Testing, Brazil, Company Share (2008-2009) 52
6 Haematology In Brazil 54
6.1 Haematology, Market Segmentation 54
6.2 Haematology Market, Brazil, Revenue Mix ($m), 2009 55
6.3 Haematology Market, Brazil, Category Contribution (%), 2009 56
6.4 Haematology Overall Revenue (2002-2016) 57
6.4.1 Haematology Reagents Revenue (2002-2016) 61
6.4.2 Immunohaematology Revenue (2002-2016) 65
6.4.3 Haemostasis Revenue (2002-2016) 69
6.4.4 Haematology Rapid Tests Revenue (2002-2016) 73
6.4.5 Haematology Cell Counters Revenue (2002-2016) 77
6.5 Haematology Distribution Share (2008-2009) 81
6.6 Haematology, Brazil, Company Share (2008-2009) 82
7 Histology And Cytology In Brazil 84
7.1 Histology and Cytology, Market Segmentation 84
7.2 Histology and Cytology Market, Brazil, Revenue Mix ($m), 2009 85
7.3 Histology and Cytology Market, Brazil, Category Contribution (%), 2009 86
7.4 Histology and Cytology Overall Revenue (2002-2016) 87
7.4.1 Histology Revenue (2002-2016) 91
7.5 Histology and Cytology Distribution Share (2008-2009) 95
7.6 Histology And Cytology, Brazil, Company Share (2008-2009) 96
8 Immuno Chemistry In Brazil 98
8.1 Immuno Chemistry, Market Segmentation 98
8.2 Immuno Chemistry Market, Brazil, Revenue Mix ($m), 2009 99
8.3 Immuno Chemistry Market, Brazil, Category Contribution (%), 2009 100
8.4 Immuno Chemistry Overall Revenue (2002-2016) 101
8.4.1 Disease Specific Immunochemistry Revenue (2002-2016) 105
8.4.2 Drug Related Testing Revenue (2002-2016) 109
8.4.3 Endocrinology Tests Revenue (2002-2016) 113
8.4.4 Immunochemistry Analyzers Revenue (2002-2016) 117
8.5 Immuno Chemistry Distribution Share (2008-2009) 121
8.6 Immuno Chemistry, Brazil, Company Share (2008-2009) 122
9 Infectious Immunology In Brazil 124
9.1 Infectious Immunology, Market Segmentation 124
9.2 Infectious Immunology Market, Brazil, Revenue Mix ($m), 2009 125
9.3 Infectious Immunology Market, Brazil, Category Contribution (%), 2009 126
9.4 Infectious Immunology Overall Revenue (2002-2016) 127
9.5 Infectious Immunology Distribution Share (2008-2009) 131
9.6 Infectious Immunology, Brazil, Company Share (2008-2009) 132
10 Microbiology Culture In Brazil 134
10.1 Microbiology Culture, Market Segmentation 134
10.2 Microbiology Culture Market, Brazil, Revenue Mix ($m), 2009 135
10.3 Microbiology Culture Market, Brazil, Category Contribution (%), 2009 136
10.4 Microbiology Culture Overall Revenue (2002-2016) 137
10.4.1 Microbiology Analyzers Revenue (2002-2016) 141
10.5 Microbiology Culture Distribution Share (2008-2009) 145
10.6 Microbiology Culture, Brazil, Company Share (2008-2009) 146
11 Overview of Key Companies in Brazil In Vitro Diagnostics Market 147
11.1 F. Hoffmann-La Roche Ltd. 147
11.1.1 Company Overview 147
11.1.2 Share in the Brazil In Vitro Diagnostics Market 147
11.2 Abbott Laboratories 148
11.2.1 Company Overview 148
11.2.2 Share in the Brazil In Vitro Diagnostics Market 148
11.3 Siemens Healthcare 149
11.3.1 Company Overview 149
11.3.2 Share in the Brazil In Vitro Diagnostics Market 149
11.4 bioMerieux S.A. 150
11.4.1 Company Overview 150
11.4.2 Share in the Brazil In Vitro Diagnostics Market 150
11.5 Beckman Coulter, Inc. 151
11.5.1 Company Overview 151
11.5.2 Share in the Brazil In Vitro Diagnostics Market 151
11.6 Ortho-Clinical Diagnostics Inc. 152
11.6.1 Company Overview 152
11.6.2 Share in the Brazil In Vitro Diagnostics Market 152
11.7 Inverness Medical Innovations, Inc. 153
11.7.1 Company Overview 153
11.8 Becton, Dickinson and Company 153
11.8.1 Company Overview 153
11.9 Bio-Rad Laboratories, Inc. 154
11.9.1 Company Overview 154
11.10 Hologic, Inc. 154
11.10.1 Company Overview 154
11.11 OLYMPUS CORPORATION 155
11.11.1 Company Overview 155
11.12 Mindray Medical International Limited 155
11.12.1 Company Overview 155
11.13 Sysmex Corporation 155
11.13.1 Company Overview 155
11.14 Ventana Medical Systems, Inc. 156
11.14.1 Company Overview 156
11.15 DiaSorin S.p.A 156
11.15.1 Company Overview 156
11.16 Qiagen N.V. 156
11.16.1 Company Overview 156
11.17 Gen-Probe Incorporated 157
11.17.1 Company Overview 157
11.18 Phadia AB 157
11.18.1 Company Overview 157
12 In Vitro Diagnostics Market Pipeline Products 158
12.1 Clinical Chemisty Market Pipeline Products 158
12.2 Immuno Chemistry Market Pipeline Products 159
12.3 Haematology Market Pipeline Products 160
12.4 Infectious Immunology Market Pipeline Products 161
12.5 Microbiology Culture Market Pipeline Products 163
12.6 Histology and Cytology Market Pipeline Products 164
12.7 Genetic Testing Market Pipeline Products 165
13 Financial Deals Landscape 167
13.1 Acquisition 167
13.1.1 Caio Auriemo Completes Sale of Stake in Diagnosticos da America 167
13.2 Partnerships 168
13.2.1 QIAGEN Enters Into Distribution Agreement with Celera 168
13.2.2 Sequenom Enters Into Licensing Agreement With Optherion 169
13.2.3 QIAGEN Enters Into Licensing Agreement With Johns Hopkins University 170
13.2.4 OraSure Technologies Enters Into An Agreement With Roche Diagnostics 171
13.2.5 Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 172
14 Recent Developments 173
14.1 Product News 173
14.1.1 Nov 18, 2009: HairDX Commercializes Genetic Test For Hair Loss In Brazil Through DermaGenoma 173
15 Appendix 174
15.1 Definitions of Markets Covered in the Report 175
15.1.1 In Vitro Diagnostics 175
15.2 Research Methodology 183
15.3 Secondary Research 184
15.4 Primary Research 184
15.5 Models 185
15.6 Forecasts 185
15.7 Expert Panels 185
15.8 GlobalData Consulting 185
15.9 Currency Conversion 186
15.10 Contact Us 186
15.11 Disclaimer 186

1.1 List of Tables
Table 1: In Vitro Diagnostics, Brazil, Overall Revenue ($m), 2002-2016 17
Table 2: In Vitro Diagnostics Market, Brazil, Category Contribution (%), 2009 19
Table 3: In Vitro Diagnostics, Brazil, Cross-Category Analysis, 2002-2016 20
Table 4: In Vitro Diagnostics, Brazil, Overall Revenue ($m), Historic, 2002-2009 22
Table 5: In Vitro Diagnostics, Brazil, Overall Revenue ($m), Forecast, 2009-2016 24
Table 6: In Vitro Diagnostics, Brazil, Company Share by Revenue ($m), 2008-2009 25
Table 7: Clinical Chemistry Market, Brazil, Category Contribution (%), 2009 28
Table 8: Clinical Chemistry, Brazil, Revenue ($m) by Segment, Historic, 2002-2009 30
Table 9: Clinical Chemistry, Brazil, Revenue ($m) by Segment, Forecast, 2009-2016 32
Table 10: Clinical Chemisty Analyzers, Brazil, Revenue ($m) by Sub-Segment, Historic, 2002-2009 34
Table 11: Clinical Chemisty Analyzers, Brazil, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 36
Table 12: Urine Analysis, Brazil, Revenue ($m) by Sub-Segment, Historic, 2002-2009 38
Table 13: Urine Analysis, Brazil, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 40
Table 14: Clinical Chemistry, Brazil, Distribution Share by Revenue ($m), 2008-2009 41
Table 15: Clinical Chemistry, Brazil, Company Share by Revenue ($m), 2008-2009 43
Table 16: Genetic Testing Market, Brazil, Category Contribution (%), 2009 46
Table 17: Genetic Testing, Brazil, Revenue ($m) by Segment, Historic, 2002-2009 48
Table 18: Genetic Testing, Brazil, Revenue ($m) by Segment, Forecast, 2009-2016 50
Table 19: Genetic Testing, Brazil, Distribution Share by Revenue ($m), 2008-2009 51
Table 20: Genetic Testing, Brazil, Company Share by Revenue ($m), 2008-2009 53
Table 21: Haematology Market, Brazil, Category Contribution (%), 2009 56
Table 22: Haematology, Brazil, Revenue ($m) by Segment, Historic, 2002-2009 58
Table 23: Haematology, Brazil, Revenue ($m) by Segment, Forecast, 2009-2016 60
Table 24: Haematology Reagents, Brazil, Revenue ($m) by Sub-Segment, Historic, 2002-2009 62
Table 25: Haematology Reagents, Brazil, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 64
Table 26: Immunohaematology, Brazil, Revenue ($m) by Sub-Segment, Historic, 2002-2009 66
Table 27: Immunohaematology, Brazil, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 68
Table 28: Haemostasis, Brazil, Revenue ($m) by Sub-Segment, Historic, 2002-2009 70
Table 29: Haemostasis, Brazil, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 72
Table 30: Haematology Rapid Tests, Brazil, Revenue ($m) by Sub-Segment, Historic, 2002-2009 74
Table 31: Haematology Rapid Tests, Brazil, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 76
Table 32: Haematology Cell Counters, Brazil, Revenue ($m) by Sub-Segment, Historic, 2002-2009 78
Table 33: Haematology Cell Counters, Brazil, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 80
Table 34: Haematology, Brazil, Distribution Share by Revenue ($m), 2008-2009 81
Table 35: Haematology, Brazil, Company Share by Revenue ($m), 2008-2009 83
Table 36: Histology and Cytology Market, Brazil, Category Contribution (%), 2009 86
Table 37: Histology And Cytology, Brazil, Revenue ($m) by Segment, Historic, 2002-2009 88
Table 38: Histology And Cytology, Brazil, Revenue ($m) by Segment, Forecast, 2009-2016 90
Table 39: Histology, Brazil, Revenue ($m) by Sub-Segment, Historic, 2002-2009 92
Table 40: Histology, Brazil, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 94
Table 41: Histology And Cytology, Brazil, Distribution Share by Revenue ($m), 2008-2009 95
Table 42: Histology And Cytology, Brazil, Company Share by Revenue ($m), 2008-2009 97
Table 43: Immuno Chemistry Market, Brazil, Category Contribution (%), 2009 100
Table 44: Immuno Chemistry, Brazil, Revenue ($m) by Segment, Historic, 2002-2009 102
Table 45: Immuno Chemistry, Brazil, Revenue ($m) by Segment, Forecast, 2009-2016 104
Table 46: Disease Specific Immunochemistry, Brazil, Revenue ($m) by Sub-Segment, Historic, 2002-2009 106
Table 47: Disease Specific Immunochemistry, Brazil, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 108
Table 48: Drug Related Testing, Brazil, Revenue ($m) by Sub-Segment, Historic, 2002-2009 110
Table 49: Drug Related Testing, Brazil, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 112
Table 50: Endocrinology Tests, Brazil, Revenue ($m) by Sub-Segment, Historic, 2002-2009 114
Table 51: Endocrinology Tests, Brazil, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 116
Table 52: Immunochemistry Analyzers, Brazil, Revenue ($m) by Sub-Segment, Historic, 2002-2009 118
Table 53: Immunochemistry Analyzers, Brazil, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 120
Table 54: Immuno Chemistry, Brazil, Distribution Share by Revenue ($m), 2008-2009 121
Table 55: Immuno Chemistry, Brazil, Company Share by Revenue ($m), 2008-2009 123
Table 56: Infectious Immunology Market, Brazil, Category Contribution (%), 2009 126
Table 57: Infectious Immunology, Brazil, Revenue ($m) by Segment, Historic, 2002-2009 128
Table 58: Infectious Immunology, Brazil, Revenue ($m) by Segment, Forecast, 2009-2016 130
Table 59: Infectious Immunology, Brazil, Distribution Share by Revenue ($m), 2008-2009 131
Table 60: Infectious Immunology, Brazil, Company Share by Revenue ($m), 2008-2009 133
Table 61: Microbiology Culture Market, Brazil, Category Contribution (%), 2009 136
Table 62: Microbiology Culture, Brazil, Revenue ($m) by Segment, Historic, 2002-2009 138
Table 63: Microbiology Culture, Brazil, Revenue ($m) by Segment, Forecast, 2009-2016 140
Table 64: Microbiology Analyzers, Brazil, Revenue ($m) by Sub-Segment, Historic, 2002-2009 142
Table 65: Microbiology Analyzers, Brazil, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 144
Table 66: Microbiology Culture, Brazil, Distribution Share by Revenue ($m), 2008-2009 145
Table 67: Microbiology Culture, Brazil, Company Share by Revenue ($m), 2008-2009 146
Table 68: Clinical Chemisty Market Pipeline Products 158
Table 69: Immuno Chemistry Market Pipeline Products 159
Table 70: Haematology Market Pipeline Products 160
Table 71: Infectious Immunology Market Pipeline Products 161
Table 72: Microbiology Culture Market Pipeline Products 163
Table 73: Histology and Cytology Market Pipeline Products 164
Table 74: Genetic Testing Market Pipeline Products 165
Table 75: Caio Auriemo Completes Sale Of Stake In Diagnosticos da America 167
Table 76: QIAGEN Enters Into Distribution Agreement With Celera 168
Table 77: Sequenom Enters Into Licensing Agreement With Optherion 169
Table 78: QIAGEN Enters Into Licensing Agreement With Johns Hopkins University 170
Table 79: OraSure Technologies Enters Into An Agreement With Roche Diagnostics 171
Table 80: Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 172
Table 81: USD to Local Currency, Brazil, Average Actual Rate 2002-2009 186

1.2 List of Figures
Figure 1: In Vitro Diagnostics, Market Segmentation 15
Figure 2: In Vitro Diagnostics, Brazil, Overall Revenue ($m), 2002-2016 16
Figure 3: In Vitro Diagnostics Market, Brazil, Revenue Mix ($m), 2009 18
Figure 4: In Vitro Diagnostics Market, Brazil, Category Contribution (%), 2009 19
Figure 5: In Vitro Diagnostics, Brazil, Cross-Category Analysis, 2002-2016 20
Figure 6: In Vitro Diagnostics, Brazil, Overall Revenue ($m), Historic, 2002-2009 21
Figure 7: In Vitro Diagnostics, Brazil, Overall Revenue ($m), Forecast, 2009-2016 23
Figure 8: In Vitro Diagnostics, Brazil, Company Share (%), 2009 25
Figure 9: Clinical Chemistry, Market Segmentation 26
Figure 10: Clinical Chemistry Market, Brazil, Revenue Mix ($m), 2009 27
Figure 11: Clinical Chemistry Market, Brazil, Category Contribution (%), 2009 28
Figure 12: Clinical Chemistry, Brazil, Revenue ($m) by Segment, Historic, 2002-2009 29
Figure 13: Clinical Chemistry, Brazil, Revenue ($m) by Segment, Forecast, 2009-2016 31
Figure 14: Clinical Chemisty Analyzers, Brazil, Revenue ($m) by Sub-Segment, Historic, 2002-2009 33
Figure 15: Clinical Chemisty Analyzers, Brazil, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 35
Figure 16: Urine Analysis, Brazil, Revenue ($m) by Sub-Segment, Historic, 2002-2009 37
Figure 17: Urine Analysis, Brazil, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 39
Figure 18: Clinical Chemistry, Brazil, Company Share (%), 2009 42
Figure 19: Genetic Testing, Market Segmentation 44
Figure 20: Genetic Testing Market, Brazil, Revenue Mix ($m), 2009 45
Figure 21: Genetic Testing Market, Brazil, Category Contribution (%), 2009 46
Figure 22: Genetic Testing, Brazil, Revenue ($m) by Segment, Historic, 2002-2009 47
Figure 23: Genetic Testing, Brazil, Revenue ($m) by Segment, Forecast, 2009-2016 49
Figure 24: Genetic Testing, Brazil, Company Share (%), 2009 52
Figure 25: Haematology, Market Segmentation 54
Figure 26: Haematology Market, Brazil, Revenue Mix ($m), 2009 55
Figure 27: Haematology Market, Brazil, Category Contribution (%), 2009 56
Figure 28: Haematology, Brazil, Revenue ($m) by Segment, Historic, 2002-2009 57
Figure 29: Haematology, Brazil, Revenue ($m) by Segment, Forecast, 2009-2016 59
Figure 30: Haematology Reagents, Brazil, Revenue ($m) by Sub-Segment, Historic, 2002-2009 61
Figure 31: Haematology Reagents, Brazil, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 63
Figure 32: Immunohaematology, Brazil, Revenue ($m) by Sub-Segment, Historic, 2002-2009 65
Figure 33: Immunohaematology, Brazil, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 67
Figure 34: Haemostasis, Brazil, Revenue ($m) by Sub-Segment, Historic, 2002-2009 69
Figure 35: Haemostasis, Brazil, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 71
Figure 36: Haematology Rapid Tests, Brazil, Revenue ($m) by Sub-Segment, Historic, 2002-2009 73
Figure 37: Haematology Rapid Tests, Brazil, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 75
Figure 38: Haematology Cell Counters, Brazil, Revenue ($m) by Sub-Segment, Historic, 2002-2009 77
Figure 39: Haematology Cell Counters, Brazil, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 79
Figure 40: Haematology, Brazil, Company Share (%), 2009 82
Figure 41: Histology and Cytology, Market Segmentation 84
Figure 42: Histology and Cytology Market, Brazil, Revenue Mix ($m), 2009 85
Figure 43: Histology and Cytology Market, Brazil, Category Contribution (%), 2009 86
Figure 44: Histology And Cytology, Brazil, Revenue ($m) by Segment, Historic, 2002-2009 87
Figure 45: Histology And Cytology, Brazil, Revenue ($m) by Segment, Forecast, 2009-2016 89
Figure 46: Histology, Brazil, Revenue ($m) by Sub-Segment, Historic, 2002-2009 91
Figure 47: Histology, Brazil, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 93
Figure 48: Histology And Cytology, Brazil, Company Share (%), 2009 96
Figure 49: Immuno Chemistry, Market Segmentation 98
Figure 50: Immuno Chemistry Market, Brazil, Revenue Mix ($m), 2009 99
Figure 51: Immuno Chemistry Market, Brazil, Category Contribution (%), 2009 100
Figure 52: Immuno Chemistry, Brazil, Revenue ($m) by Segment, Historic, 2002-2009 101
Figure 53: Immuno Chemistry, Brazil, Revenue ($m) by Segment, Forecast, 2009-2016 103
Figure 54: Disease Specific Immunochemistry, Brazil, Revenue ($m) by Sub-Segment, Historic, 2002-2009 105
Figure 55: Disease Specific Immunochemistry, Brazil, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 107
Figure 56: Drug Related Testing, Brazil, Revenue ($m) by Sub-Segment, Historic, 2002-2009 109
Figure 57: Drug Related Testing, Brazil, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 111
Figure 58: Endocrinology Tests, Brazil, Revenue ($m) by Sub-Segment, Historic, 2002-2009 113
Figure 59: Endocrinology Tests, Brazil, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 115
Figure 60: Immunochemistry Analyzers, Brazil, Revenue ($m) by Sub-Segment, Historic, 2002-2009 117
Figure 61: Immunochemistry Analyzers, Brazil, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 119
Figure 62: Immuno Chemistry, Brazil, Company Share (%), 2009 122
Figure 63: Infectious Immunology, Market Segmentation 124
Figure 64: Infectious Immunology Market, Brazil, Revenue Mix ($m), 2009 125
Figure 65: Infectious Immunology Market, Brazil, Category Contribution (%), 2009 126
Figure 66: Infectious Immunology, Brazil, Revenue ($m) by Segment, Historic, 2002-2009 127
Figure 67: Infectious Immunology, Brazil, Revenue ($m) by Segment, Forecast, 2009-2016 129
Figure 68: Infectious Immunology, Brazil, Company Share (%), 2009 132
Figure 69: Microbiology Culture, Market Segmentation 134
Figure 70: Microbiology Culture Market, Brazil, Revenue Mix ($m), 2009 135
Figure 71: Microbiology Culture Market, Brazil, Category Contribution (%), 2009 136
Figure 72: Microbiology Culture, Brazil, Revenue ($m) by Segment, Historic, 2002-2009 137
Figure 73: Microbiology Culture, Brazil, Revenue ($m) by Segment, Forecast, 2009-2016 139
Figure 74: Microbiology Analyzers, Brazil, Revenue ($m) by Sub-Segment, Historic, 2002-2009 141
Figure 75: Microbiology Analyzers, Brazil, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 143
Figure 76: Microbiology Culture, Brazil, Company Share (%), 2009 146
Figure 77: F. Hoffmann-La Roche Ltd., Company Share (%),Brazil In Vitro Diagnostics Market, 2009 147
Figure 78: Abbott Laboratories, Company Share (%),Brazil In Vitro Diagnostics Market, 2009 148
Figure 79: Siemens Healthcare, Company Share (%),Brazil In Vitro Diagnostics Market, 2009 149
Figure 80: bioMerieux S.A., Company Share (%),Brazil In Vitro Diagnostics Market, 2009 150
Figure 81: Beckman Coulter, Inc., Company Share (%),Brazil In Vitro Diagnostics Market, 2009 151
Figure 82: Ortho-Clinical Diagnostics Inc., Company Share (%),Brazil In Vitro Diagnostics Market, 2009 152
Figure 83: GlobalData Methodology 183